Global Untargeted Metabolomics Supply, Demand and Key Producers, 2026-2032
The global Untargeted Metabolomics market size is expected to reach $ 3213 million by 2032, rising at a market growth of 9.6% CAGR during the forecast period (2026-2032).
Untargeted metabolomics is a study in which all detectable metabolites are identified and quantitated for analyzing the overall metabolic characteristics and discovering metabolic mechanisms behind the phenomenon. Also known as discovery metabolomics, untargeted metabolomics is a powerful tool for large-scale early phase diagnosis and discovery of new biomarkers. Compared to traditional metabolic quantitation methods, untargeted metabolomics is a high-throughput technology, enabling more comprehensive analysis with more accurate data acquisition, eliminating biased research direction.
This report studies the global Untargeted Metabolomics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Untargeted Metabolomics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Untargeted Metabolomics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Untargeted Metabolomics total market, 2021-2032, (USD Million)
Global Untargeted Metabolomics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Untargeted Metabolomics total market, key domestic companies, and share, (USD Million)
Global Untargeted Metabolomics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Untargeted Metabolomics total market by Type, CAGR, 2021-2032, (USD Million)
Global Untargeted Metabolomics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Untargeted Metabolomics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Proteomics, Metabolon, Alfa Chemistry, Novelgene Technologies, MtoZ-Biolabs Inc., CD Genomics, Metware Biotechnology Inc (Metware), BGI Genomics, APPLIED PROTEIN TECHNOLOGY, Suzhou PANOMIX Biomedical Tech Co.,Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Untargeted Metabolomics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Untargeted Metabolomics Market, By Region:
1. How big is the global Untargeted Metabolomics market?
2. What is the demand of the global Untargeted Metabolomics market?
3. What is the year over year growth of the global Untargeted Metabolomics market?
4. What is the total value of the global Untargeted Metabolomics market?
5. Who are the Major Players in the global Untargeted Metabolomics market?
6. What are the growth factors driving the market demand?
Untargeted metabolomics is a study in which all detectable metabolites are identified and quantitated for analyzing the overall metabolic characteristics and discovering metabolic mechanisms behind the phenomenon. Also known as discovery metabolomics, untargeted metabolomics is a powerful tool for large-scale early phase diagnosis and discovery of new biomarkers. Compared to traditional metabolic quantitation methods, untargeted metabolomics is a high-throughput technology, enabling more comprehensive analysis with more accurate data acquisition, eliminating biased research direction.
This report studies the global Untargeted Metabolomics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Untargeted Metabolomics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Untargeted Metabolomics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Untargeted Metabolomics total market, 2021-2032, (USD Million)
Global Untargeted Metabolomics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Untargeted Metabolomics total market, key domestic companies, and share, (USD Million)
Global Untargeted Metabolomics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Untargeted Metabolomics total market by Type, CAGR, 2021-2032, (USD Million)
Global Untargeted Metabolomics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Untargeted Metabolomics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Proteomics, Metabolon, Alfa Chemistry, Novelgene Technologies, MtoZ-Biolabs Inc., CD Genomics, Metware Biotechnology Inc (Metware), BGI Genomics, APPLIED PROTEIN TECHNOLOGY, Suzhou PANOMIX Biomedical Tech Co.,Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Untargeted Metabolomics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Untargeted Metabolomics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Plant Untargeted Metabolomics
- Human Untargeted Metabolomics
- Other
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Creative Proteomics
- Metabolon
- Alfa Chemistry
- Novelgene Technologies
- MtoZ-Biolabs Inc.
- CD Genomics
- Metware Biotechnology Inc (Metware)
- BGI Genomics
- APPLIED PROTEIN TECHNOLOGY
- Suzhou PANOMIX Biomedical Tech Co.,Ltd
- OBiO Technology ( Shanghai ) Corp.,Ltd.
- Beijing Huayi innovation & BioTechnology Co., Ltd
- Abace Biotechnology
- Metabo-Profile
1. How big is the global Untargeted Metabolomics market?
2. What is the demand of the global Untargeted Metabolomics market?
3. What is the year over year growth of the global Untargeted Metabolomics market?
4. What is the total value of the global Untargeted Metabolomics market?
5. Who are the Major Players in the global Untargeted Metabolomics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Untargeted Metabolomics Introduction
1.2 World Untargeted Metabolomics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Untargeted Metabolomics Total Market by Region (by Headquarter Location)
1.3.1 World Untargeted Metabolomics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.3 China Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.4 Europe Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.5 Japan Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.6 South Korea Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.7 ASEAN Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.8 India Based Company Untargeted Metabolomics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Untargeted Metabolomics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Untargeted Metabolomics Consumption Value (2021-2032)
2.2 World Untargeted Metabolomics Consumption Value by Region
2.2.1 World Untargeted Metabolomics Consumption Value by Region (2021-2026)
2.2.2 World Untargeted Metabolomics Consumption Value Forecast by Region (2027-2032)
2.3 United States Untargeted Metabolomics Consumption Value (2021-2032)
2.4 China Untargeted Metabolomics Consumption Value (2021-2032)
2.5 Europe Untargeted Metabolomics Consumption Value (2021-2032)
2.6 Japan Untargeted Metabolomics Consumption Value (2021-2032)
2.7 South Korea Untargeted Metabolomics Consumption Value (2021-2032)
2.8 ASEAN Untargeted Metabolomics Consumption Value (2021-2032)
2.9 India Untargeted Metabolomics Consumption Value (2021-2032)
3 WORLD UNTARGETED METABOLOMICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Untargeted Metabolomics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Untargeted Metabolomics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Untargeted Metabolomics in 2025
3.2.3 Global Concentration Ratios (CR8) for Untargeted Metabolomics in 2025
3.3 Untargeted Metabolomics Company Evaluation Quadrant
3.4 Untargeted Metabolomics Market: Overall Company Footprint Analysis
3.4.1 Untargeted Metabolomics Market: Region Footprint
3.4.2 Untargeted Metabolomics Market: Company Product Type Footprint
3.4.3 Untargeted Metabolomics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Untargeted Metabolomics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Untargeted Metabolomics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Untargeted Metabolomics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Untargeted Metabolomics Consumption Value Comparison
4.2.1 United States VS China: Untargeted Metabolomics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Untargeted Metabolomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Untargeted Metabolomics Companies and Market Share, 2021-2026
4.3.1 United States Based Untargeted Metabolomics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Untargeted Metabolomics Revenue, (2021-2026)
4.4 China Based Companies Untargeted Metabolomics Revenue and Market Share, 2021-2026
4.4.1 China Based Untargeted Metabolomics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Untargeted Metabolomics Revenue, (2021-2026)
4.5 Rest of World Based Untargeted Metabolomics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Untargeted Metabolomics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Untargeted Metabolomics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Untargeted Metabolomics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Plant Untargeted Metabolomics
5.2.2 Human Untargeted Metabolomics
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Untargeted Metabolomics Market Size by Type (2021-2026)
5.3.2 World Untargeted Metabolomics Market Size by Type (2027-2032)
5.3.3 World Untargeted Metabolomics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Untargeted Metabolomics Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Academic and Research Institutions
6.2.2 Pharmaceutical and Biotechnology Companies
6.3 Market Segment by Application
6.3.1 World Untargeted Metabolomics Market Size by Application (2021-2026)
6.3.2 World Untargeted Metabolomics Market Size by Application (2027-2032)
6.3.3 World Untargeted Metabolomics Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Creative Proteomics
7.1.1 Creative Proteomics Details
7.1.2 Creative Proteomics Major Business
7.1.3 Creative Proteomics Untargeted Metabolomics Product and Services
7.1.4 Creative Proteomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Creative Proteomics Recent Developments/Updates
7.1.6 Creative Proteomics Competitive Strengths & Weaknesses
7.2 Metabolon
7.2.1 Metabolon Details
7.2.2 Metabolon Major Business
7.2.3 Metabolon Untargeted Metabolomics Product and Services
7.2.4 Metabolon Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Metabolon Recent Developments/Updates
7.2.6 Metabolon Competitive Strengths & Weaknesses
7.3 Alfa Chemistry
7.3.1 Alfa Chemistry Details
7.3.2 Alfa Chemistry Major Business
7.3.3 Alfa Chemistry Untargeted Metabolomics Product and Services
7.3.4 Alfa Chemistry Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Alfa Chemistry Recent Developments/Updates
7.3.6 Alfa Chemistry Competitive Strengths & Weaknesses
7.4 Novelgene Technologies
7.4.1 Novelgene Technologies Details
7.4.2 Novelgene Technologies Major Business
7.4.3 Novelgene Technologies Untargeted Metabolomics Product and Services
7.4.4 Novelgene Technologies Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Novelgene Technologies Recent Developments/Updates
7.4.6 Novelgene Technologies Competitive Strengths & Weaknesses
7.5 MtoZ-Biolabs Inc.
7.5.1 MtoZ-Biolabs Inc. Details
7.5.2 MtoZ-Biolabs Inc. Major Business
7.5.3 MtoZ-Biolabs Inc. Untargeted Metabolomics Product and Services
7.5.4 MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 MtoZ-Biolabs Inc. Recent Developments/Updates
7.5.6 MtoZ-Biolabs Inc. Competitive Strengths & Weaknesses
7.6 CD Genomics
7.6.1 CD Genomics Details
7.6.2 CD Genomics Major Business
7.6.3 CD Genomics Untargeted Metabolomics Product and Services
7.6.4 CD Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 CD Genomics Recent Developments/Updates
7.6.6 CD Genomics Competitive Strengths & Weaknesses
7.7 Metware Biotechnology Inc (Metware)
7.7.1 Metware Biotechnology Inc (Metware) Details
7.7.2 Metware Biotechnology Inc (Metware) Major Business
7.7.3 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product and Services
7.7.4 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Metware Biotechnology Inc (Metware) Recent Developments/Updates
7.7.6 Metware Biotechnology Inc (Metware) Competitive Strengths & Weaknesses
7.8 BGI Genomics
7.8.1 BGI Genomics Details
7.8.2 BGI Genomics Major Business
7.8.3 BGI Genomics Untargeted Metabolomics Product and Services
7.8.4 BGI Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 BGI Genomics Recent Developments/Updates
7.8.6 BGI Genomics Competitive Strengths & Weaknesses
7.9 APPLIED PROTEIN TECHNOLOGY
7.9.1 APPLIED PROTEIN TECHNOLOGY Details
7.9.2 APPLIED PROTEIN TECHNOLOGY Major Business
7.9.3 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product and Services
7.9.4 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 APPLIED PROTEIN TECHNOLOGY Recent Developments/Updates
7.9.6 APPLIED PROTEIN TECHNOLOGY Competitive Strengths & Weaknesses
7.10 Suzhou PANOMIX Biomedical Tech Co.,Ltd
7.10.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Details
7.10.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Major Business
7.10.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product and Services
7.10.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments/Updates
7.10.6 Suzhou PANOMIX Biomedical Tech Co.,Ltd Competitive Strengths & Weaknesses
7.11 OBiO Technology ( Shanghai ) Corp.,Ltd.
7.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Details
7.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Major Business
7.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product and Services
7.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments/Updates
7.11.6 OBiO Technology ( Shanghai ) Corp.,Ltd. Competitive Strengths & Weaknesses
7.12 Beijing Huayi innovation & BioTechnology Co., Ltd
7.12.1 Beijing Huayi innovation & BioTechnology Co., Ltd Details
7.12.2 Beijing Huayi innovation & BioTechnology Co., Ltd Major Business
7.12.3 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product and Services
7.12.4 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Beijing Huayi innovation & BioTechnology Co., Ltd Recent Developments/Updates
7.12.6 Beijing Huayi innovation & BioTechnology Co., Ltd Competitive Strengths & Weaknesses
7.13 Abace Biotechnology
7.13.1 Abace Biotechnology Details
7.13.2 Abace Biotechnology Major Business
7.13.3 Abace Biotechnology Untargeted Metabolomics Product and Services
7.13.4 Abace Biotechnology Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Abace Biotechnology Recent Developments/Updates
7.13.6 Abace Biotechnology Competitive Strengths & Weaknesses
7.14 Metabo-Profile
7.14.1 Metabo-Profile Details
7.14.2 Metabo-Profile Major Business
7.14.3 Metabo-Profile Untargeted Metabolomics Product and Services
7.14.4 Metabo-Profile Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Metabo-Profile Recent Developments/Updates
7.14.6 Metabo-Profile Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Untargeted Metabolomics Industry Chain
8.2 Untargeted Metabolomics Upstream Analysis
8.3 Untargeted Metabolomics Midstream Analysis
8.4 Untargeted Metabolomics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Untargeted Metabolomics Introduction
1.2 World Untargeted Metabolomics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Untargeted Metabolomics Total Market by Region (by Headquarter Location)
1.3.1 World Untargeted Metabolomics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.3 China Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.4 Europe Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.5 Japan Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.6 South Korea Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.7 ASEAN Based Company Untargeted Metabolomics Revenue (2021-2032)
1.3.8 India Based Company Untargeted Metabolomics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Untargeted Metabolomics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Untargeted Metabolomics Consumption Value (2021-2032)
2.2 World Untargeted Metabolomics Consumption Value by Region
2.2.1 World Untargeted Metabolomics Consumption Value by Region (2021-2026)
2.2.2 World Untargeted Metabolomics Consumption Value Forecast by Region (2027-2032)
2.3 United States Untargeted Metabolomics Consumption Value (2021-2032)
2.4 China Untargeted Metabolomics Consumption Value (2021-2032)
2.5 Europe Untargeted Metabolomics Consumption Value (2021-2032)
2.6 Japan Untargeted Metabolomics Consumption Value (2021-2032)
2.7 South Korea Untargeted Metabolomics Consumption Value (2021-2032)
2.8 ASEAN Untargeted Metabolomics Consumption Value (2021-2032)
2.9 India Untargeted Metabolomics Consumption Value (2021-2032)
3 WORLD UNTARGETED METABOLOMICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Untargeted Metabolomics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Untargeted Metabolomics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Untargeted Metabolomics in 2025
3.2.3 Global Concentration Ratios (CR8) for Untargeted Metabolomics in 2025
3.3 Untargeted Metabolomics Company Evaluation Quadrant
3.4 Untargeted Metabolomics Market: Overall Company Footprint Analysis
3.4.1 Untargeted Metabolomics Market: Region Footprint
3.4.2 Untargeted Metabolomics Market: Company Product Type Footprint
3.4.3 Untargeted Metabolomics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Untargeted Metabolomics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Untargeted Metabolomics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Untargeted Metabolomics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Untargeted Metabolomics Consumption Value Comparison
4.2.1 United States VS China: Untargeted Metabolomics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Untargeted Metabolomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Untargeted Metabolomics Companies and Market Share, 2021-2026
4.3.1 United States Based Untargeted Metabolomics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Untargeted Metabolomics Revenue, (2021-2026)
4.4 China Based Companies Untargeted Metabolomics Revenue and Market Share, 2021-2026
4.4.1 China Based Untargeted Metabolomics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Untargeted Metabolomics Revenue, (2021-2026)
4.5 Rest of World Based Untargeted Metabolomics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Untargeted Metabolomics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Untargeted Metabolomics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Untargeted Metabolomics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Plant Untargeted Metabolomics
5.2.2 Human Untargeted Metabolomics
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Untargeted Metabolomics Market Size by Type (2021-2026)
5.3.2 World Untargeted Metabolomics Market Size by Type (2027-2032)
5.3.3 World Untargeted Metabolomics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Untargeted Metabolomics Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Academic and Research Institutions
6.2.2 Pharmaceutical and Biotechnology Companies
6.3 Market Segment by Application
6.3.1 World Untargeted Metabolomics Market Size by Application (2021-2026)
6.3.2 World Untargeted Metabolomics Market Size by Application (2027-2032)
6.3.3 World Untargeted Metabolomics Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Creative Proteomics
7.1.1 Creative Proteomics Details
7.1.2 Creative Proteomics Major Business
7.1.3 Creative Proteomics Untargeted Metabolomics Product and Services
7.1.4 Creative Proteomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Creative Proteomics Recent Developments/Updates
7.1.6 Creative Proteomics Competitive Strengths & Weaknesses
7.2 Metabolon
7.2.1 Metabolon Details
7.2.2 Metabolon Major Business
7.2.3 Metabolon Untargeted Metabolomics Product and Services
7.2.4 Metabolon Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Metabolon Recent Developments/Updates
7.2.6 Metabolon Competitive Strengths & Weaknesses
7.3 Alfa Chemistry
7.3.1 Alfa Chemistry Details
7.3.2 Alfa Chemistry Major Business
7.3.3 Alfa Chemistry Untargeted Metabolomics Product and Services
7.3.4 Alfa Chemistry Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Alfa Chemistry Recent Developments/Updates
7.3.6 Alfa Chemistry Competitive Strengths & Weaknesses
7.4 Novelgene Technologies
7.4.1 Novelgene Technologies Details
7.4.2 Novelgene Technologies Major Business
7.4.3 Novelgene Technologies Untargeted Metabolomics Product and Services
7.4.4 Novelgene Technologies Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Novelgene Technologies Recent Developments/Updates
7.4.6 Novelgene Technologies Competitive Strengths & Weaknesses
7.5 MtoZ-Biolabs Inc.
7.5.1 MtoZ-Biolabs Inc. Details
7.5.2 MtoZ-Biolabs Inc. Major Business
7.5.3 MtoZ-Biolabs Inc. Untargeted Metabolomics Product and Services
7.5.4 MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 MtoZ-Biolabs Inc. Recent Developments/Updates
7.5.6 MtoZ-Biolabs Inc. Competitive Strengths & Weaknesses
7.6 CD Genomics
7.6.1 CD Genomics Details
7.6.2 CD Genomics Major Business
7.6.3 CD Genomics Untargeted Metabolomics Product and Services
7.6.4 CD Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 CD Genomics Recent Developments/Updates
7.6.6 CD Genomics Competitive Strengths & Weaknesses
7.7 Metware Biotechnology Inc (Metware)
7.7.1 Metware Biotechnology Inc (Metware) Details
7.7.2 Metware Biotechnology Inc (Metware) Major Business
7.7.3 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product and Services
7.7.4 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Metware Biotechnology Inc (Metware) Recent Developments/Updates
7.7.6 Metware Biotechnology Inc (Metware) Competitive Strengths & Weaknesses
7.8 BGI Genomics
7.8.1 BGI Genomics Details
7.8.2 BGI Genomics Major Business
7.8.3 BGI Genomics Untargeted Metabolomics Product and Services
7.8.4 BGI Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 BGI Genomics Recent Developments/Updates
7.8.6 BGI Genomics Competitive Strengths & Weaknesses
7.9 APPLIED PROTEIN TECHNOLOGY
7.9.1 APPLIED PROTEIN TECHNOLOGY Details
7.9.2 APPLIED PROTEIN TECHNOLOGY Major Business
7.9.3 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product and Services
7.9.4 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 APPLIED PROTEIN TECHNOLOGY Recent Developments/Updates
7.9.6 APPLIED PROTEIN TECHNOLOGY Competitive Strengths & Weaknesses
7.10 Suzhou PANOMIX Biomedical Tech Co.,Ltd
7.10.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Details
7.10.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Major Business
7.10.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product and Services
7.10.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments/Updates
7.10.6 Suzhou PANOMIX Biomedical Tech Co.,Ltd Competitive Strengths & Weaknesses
7.11 OBiO Technology ( Shanghai ) Corp.,Ltd.
7.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Details
7.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Major Business
7.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product and Services
7.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments/Updates
7.11.6 OBiO Technology ( Shanghai ) Corp.,Ltd. Competitive Strengths & Weaknesses
7.12 Beijing Huayi innovation & BioTechnology Co., Ltd
7.12.1 Beijing Huayi innovation & BioTechnology Co., Ltd Details
7.12.2 Beijing Huayi innovation & BioTechnology Co., Ltd Major Business
7.12.3 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product and Services
7.12.4 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Beijing Huayi innovation & BioTechnology Co., Ltd Recent Developments/Updates
7.12.6 Beijing Huayi innovation & BioTechnology Co., Ltd Competitive Strengths & Weaknesses
7.13 Abace Biotechnology
7.13.1 Abace Biotechnology Details
7.13.2 Abace Biotechnology Major Business
7.13.3 Abace Biotechnology Untargeted Metabolomics Product and Services
7.13.4 Abace Biotechnology Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Abace Biotechnology Recent Developments/Updates
7.13.6 Abace Biotechnology Competitive Strengths & Weaknesses
7.14 Metabo-Profile
7.14.1 Metabo-Profile Details
7.14.2 Metabo-Profile Major Business
7.14.3 Metabo-Profile Untargeted Metabolomics Product and Services
7.14.4 Metabo-Profile Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Metabo-Profile Recent Developments/Updates
7.14.6 Metabo-Profile Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Untargeted Metabolomics Industry Chain
8.2 Untargeted Metabolomics Upstream Analysis
8.3 Untargeted Metabolomics Midstream Analysis
8.4 Untargeted Metabolomics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Untargeted Metabolomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Untargeted Metabolomics Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Untargeted Metabolomics Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Untargeted Metabolomics Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Untargeted Metabolomics Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Untargeted Metabolomics Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Untargeted Metabolomics Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Untargeted Metabolomics Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Untargeted Metabolomics Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Untargeted Metabolomics Players in 2025
Table 12. World Untargeted Metabolomics Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Untargeted Metabolomics Company Evaluation Quadrant
Table 14. Head Office of Key Untargeted Metabolomics Players
Table 15. Untargeted Metabolomics Market: Company Product Type Footprint
Table 16. Untargeted Metabolomics Market: Company Product Application Footprint
Table 17. Untargeted Metabolomics Mergers & Acquisitions Activity
Table 18. United States VS China Untargeted Metabolomics Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Untargeted Metabolomics Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Untargeted Metabolomics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Untargeted Metabolomics Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Untargeted Metabolomics Revenue Market Share (2021-2026)
Table 23. China Based Untargeted Metabolomics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Untargeted Metabolomics Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Untargeted Metabolomics Revenue Market Share (2021-2026)
Table 26. Rest of World Based Untargeted Metabolomics Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Untargeted Metabolomics Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Untargeted Metabolomics Revenue Market Share (2021-2026)
Table 29. World Untargeted Metabolomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Untargeted Metabolomics Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Untargeted Metabolomics Market Size by Type (2027-2032) & (USD Million)
Table 32. World Untargeted Metabolomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Untargeted Metabolomics Market Size by Application (2021-2026) & (USD Million)
Table 34. World Untargeted Metabolomics Market Size by Application (2027-2032) & (USD Million)
Table 35. Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table 36. Creative Proteomics Major Business
Table 37. Creative Proteomics Untargeted Metabolomics Product and Services
Table 38. Creative Proteomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Creative Proteomics Recent Developments/Updates
Table 40. Creative Proteomics Competitive Strengths & Weaknesses
Table 41. Metabolon Basic Information, Manufacturing Base and Competitors
Table 42. Metabolon Major Business
Table 43. Metabolon Untargeted Metabolomics Product and Services
Table 44. Metabolon Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Metabolon Recent Developments/Updates
Table 46. Metabolon Competitive Strengths & Weaknesses
Table 47. Alfa Chemistry Basic Information, Manufacturing Base and Competitors
Table 48. Alfa Chemistry Major Business
Table 49. Alfa Chemistry Untargeted Metabolomics Product and Services
Table 50. Alfa Chemistry Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Alfa Chemistry Recent Developments/Updates
Table 52. Alfa Chemistry Competitive Strengths & Weaknesses
Table 53. Novelgene Technologies Basic Information, Manufacturing Base and Competitors
Table 54. Novelgene Technologies Major Business
Table 55. Novelgene Technologies Untargeted Metabolomics Product and Services
Table 56. Novelgene Technologies Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Novelgene Technologies Recent Developments/Updates
Table 58. Novelgene Technologies Competitive Strengths & Weaknesses
Table 59. MtoZ-Biolabs Inc. Basic Information, Manufacturing Base and Competitors
Table 60. MtoZ-Biolabs Inc. Major Business
Table 61. MtoZ-Biolabs Inc. Untargeted Metabolomics Product and Services
Table 62. MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MtoZ-Biolabs Inc. Recent Developments/Updates
Table 64. MtoZ-Biolabs Inc. Competitive Strengths & Weaknesses
Table 65. CD Genomics Basic Information, Manufacturing Base and Competitors
Table 66. CD Genomics Major Business
Table 67. CD Genomics Untargeted Metabolomics Product and Services
Table 68. CD Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CD Genomics Recent Developments/Updates
Table 70. CD Genomics Competitive Strengths & Weaknesses
Table 71. Metware Biotechnology Inc (Metware) Basic Information, Manufacturing Base and Competitors
Table 72. Metware Biotechnology Inc (Metware) Major Business
Table 73. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product and Services
Table 74. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Metware Biotechnology Inc (Metware) Recent Developments/Updates
Table 76. Metware Biotechnology Inc (Metware) Competitive Strengths & Weaknesses
Table 77. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 78. BGI Genomics Major Business
Table 79. BGI Genomics Untargeted Metabolomics Product and Services
Table 80. BGI Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. BGI Genomics Recent Developments/Updates
Table 82. BGI Genomics Competitive Strengths & Weaknesses
Table 83. APPLIED PROTEIN TECHNOLOGY Basic Information, Manufacturing Base and Competitors
Table 84. APPLIED PROTEIN TECHNOLOGY Major Business
Table 85. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product and Services
Table 86. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. APPLIED PROTEIN TECHNOLOGY Recent Developments/Updates
Table 88. APPLIED PROTEIN TECHNOLOGY Competitive Strengths & Weaknesses
Table 89. Suzhou PANOMIX Biomedical Tech Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 90. Suzhou PANOMIX Biomedical Tech Co.,Ltd Major Business
Table 91. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product and Services
Table 92. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments/Updates
Table 94. Suzhou PANOMIX Biomedical Tech Co.,Ltd Competitive Strengths & Weaknesses
Table 95. OBiO Technology ( Shanghai ) Corp.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 96. OBiO Technology ( Shanghai ) Corp.,Ltd. Major Business
Table 97. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product and Services
Table 98. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments/Updates
Table 100. OBiO Technology ( Shanghai ) Corp.,Ltd. Competitive Strengths & Weaknesses
Table 101. Beijing Huayi innovation & BioTechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 102. Beijing Huayi innovation & BioTechnology Co., Ltd Major Business
Table 103. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product and Services
Table 104. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Beijing Huayi innovation & BioTechnology Co., Ltd Recent Developments/Updates
Table 106. Beijing Huayi innovation & BioTechnology Co., Ltd Competitive Strengths & Weaknesses
Table 107. Abace Biotechnology Basic Information, Manufacturing Base and Competitors
Table 108. Abace Biotechnology Major Business
Table 109. Abace Biotechnology Untargeted Metabolomics Product and Services
Table 110. Abace Biotechnology Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Abace Biotechnology Recent Developments/Updates
Table 112. Abace Biotechnology Competitive Strengths & Weaknesses
Table 113. Metabo-Profile Basic Information, Manufacturing Base and Competitors
Table 114. Metabo-Profile Major Business
Table 115. Metabo-Profile Untargeted Metabolomics Product and Services
Table 116. Metabo-Profile Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Metabo-Profile Recent Developments/Updates
Table 118. Metabo-Profile Competitive Strengths & Weaknesses
Table 119. Global Key Players of Untargeted Metabolomics Upstream (Raw Materials)
Table 120. Global Untargeted Metabolomics Typical Customers
Table 1. World Untargeted Metabolomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Untargeted Metabolomics Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Untargeted Metabolomics Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Untargeted Metabolomics Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Untargeted Metabolomics Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Untargeted Metabolomics Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Untargeted Metabolomics Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Untargeted Metabolomics Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Untargeted Metabolomics Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Untargeted Metabolomics Players in 2025
Table 12. World Untargeted Metabolomics Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Untargeted Metabolomics Company Evaluation Quadrant
Table 14. Head Office of Key Untargeted Metabolomics Players
Table 15. Untargeted Metabolomics Market: Company Product Type Footprint
Table 16. Untargeted Metabolomics Market: Company Product Application Footprint
Table 17. Untargeted Metabolomics Mergers & Acquisitions Activity
Table 18. United States VS China Untargeted Metabolomics Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Untargeted Metabolomics Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Untargeted Metabolomics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Untargeted Metabolomics Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Untargeted Metabolomics Revenue Market Share (2021-2026)
Table 23. China Based Untargeted Metabolomics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Untargeted Metabolomics Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Untargeted Metabolomics Revenue Market Share (2021-2026)
Table 26. Rest of World Based Untargeted Metabolomics Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Untargeted Metabolomics Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Untargeted Metabolomics Revenue Market Share (2021-2026)
Table 29. World Untargeted Metabolomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Untargeted Metabolomics Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Untargeted Metabolomics Market Size by Type (2027-2032) & (USD Million)
Table 32. World Untargeted Metabolomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Untargeted Metabolomics Market Size by Application (2021-2026) & (USD Million)
Table 34. World Untargeted Metabolomics Market Size by Application (2027-2032) & (USD Million)
Table 35. Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table 36. Creative Proteomics Major Business
Table 37. Creative Proteomics Untargeted Metabolomics Product and Services
Table 38. Creative Proteomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Creative Proteomics Recent Developments/Updates
Table 40. Creative Proteomics Competitive Strengths & Weaknesses
Table 41. Metabolon Basic Information, Manufacturing Base and Competitors
Table 42. Metabolon Major Business
Table 43. Metabolon Untargeted Metabolomics Product and Services
Table 44. Metabolon Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Metabolon Recent Developments/Updates
Table 46. Metabolon Competitive Strengths & Weaknesses
Table 47. Alfa Chemistry Basic Information, Manufacturing Base and Competitors
Table 48. Alfa Chemistry Major Business
Table 49. Alfa Chemistry Untargeted Metabolomics Product and Services
Table 50. Alfa Chemistry Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Alfa Chemistry Recent Developments/Updates
Table 52. Alfa Chemistry Competitive Strengths & Weaknesses
Table 53. Novelgene Technologies Basic Information, Manufacturing Base and Competitors
Table 54. Novelgene Technologies Major Business
Table 55. Novelgene Technologies Untargeted Metabolomics Product and Services
Table 56. Novelgene Technologies Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Novelgene Technologies Recent Developments/Updates
Table 58. Novelgene Technologies Competitive Strengths & Weaknesses
Table 59. MtoZ-Biolabs Inc. Basic Information, Manufacturing Base and Competitors
Table 60. MtoZ-Biolabs Inc. Major Business
Table 61. MtoZ-Biolabs Inc. Untargeted Metabolomics Product and Services
Table 62. MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MtoZ-Biolabs Inc. Recent Developments/Updates
Table 64. MtoZ-Biolabs Inc. Competitive Strengths & Weaknesses
Table 65. CD Genomics Basic Information, Manufacturing Base and Competitors
Table 66. CD Genomics Major Business
Table 67. CD Genomics Untargeted Metabolomics Product and Services
Table 68. CD Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CD Genomics Recent Developments/Updates
Table 70. CD Genomics Competitive Strengths & Weaknesses
Table 71. Metware Biotechnology Inc (Metware) Basic Information, Manufacturing Base and Competitors
Table 72. Metware Biotechnology Inc (Metware) Major Business
Table 73. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product and Services
Table 74. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Metware Biotechnology Inc (Metware) Recent Developments/Updates
Table 76. Metware Biotechnology Inc (Metware) Competitive Strengths & Weaknesses
Table 77. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 78. BGI Genomics Major Business
Table 79. BGI Genomics Untargeted Metabolomics Product and Services
Table 80. BGI Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. BGI Genomics Recent Developments/Updates
Table 82. BGI Genomics Competitive Strengths & Weaknesses
Table 83. APPLIED PROTEIN TECHNOLOGY Basic Information, Manufacturing Base and Competitors
Table 84. APPLIED PROTEIN TECHNOLOGY Major Business
Table 85. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product and Services
Table 86. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. APPLIED PROTEIN TECHNOLOGY Recent Developments/Updates
Table 88. APPLIED PROTEIN TECHNOLOGY Competitive Strengths & Weaknesses
Table 89. Suzhou PANOMIX Biomedical Tech Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 90. Suzhou PANOMIX Biomedical Tech Co.,Ltd Major Business
Table 91. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product and Services
Table 92. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments/Updates
Table 94. Suzhou PANOMIX Biomedical Tech Co.,Ltd Competitive Strengths & Weaknesses
Table 95. OBiO Technology ( Shanghai ) Corp.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 96. OBiO Technology ( Shanghai ) Corp.,Ltd. Major Business
Table 97. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product and Services
Table 98. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments/Updates
Table 100. OBiO Technology ( Shanghai ) Corp.,Ltd. Competitive Strengths & Weaknesses
Table 101. Beijing Huayi innovation & BioTechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 102. Beijing Huayi innovation & BioTechnology Co., Ltd Major Business
Table 103. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product and Services
Table 104. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Beijing Huayi innovation & BioTechnology Co., Ltd Recent Developments/Updates
Table 106. Beijing Huayi innovation & BioTechnology Co., Ltd Competitive Strengths & Weaknesses
Table 107. Abace Biotechnology Basic Information, Manufacturing Base and Competitors
Table 108. Abace Biotechnology Major Business
Table 109. Abace Biotechnology Untargeted Metabolomics Product and Services
Table 110. Abace Biotechnology Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Abace Biotechnology Recent Developments/Updates
Table 112. Abace Biotechnology Competitive Strengths & Weaknesses
Table 113. Metabo-Profile Basic Information, Manufacturing Base and Competitors
Table 114. Metabo-Profile Major Business
Table 115. Metabo-Profile Untargeted Metabolomics Product and Services
Table 116. Metabo-Profile Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Metabo-Profile Recent Developments/Updates
Table 118. Metabo-Profile Competitive Strengths & Weaknesses
Table 119. Global Key Players of Untargeted Metabolomics Upstream (Raw Materials)
Table 120. Global Untargeted Metabolomics Typical Customers
LIST OF FIGURES
Figure 1. Untargeted Metabolomics Picture
Figure 2. World Untargeted Metabolomics Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Untargeted Metabolomics Total Revenue (2021-2032) & (USD Million)
Figure 4. World Untargeted Metabolomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Untargeted Metabolomics Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 13. Untargeted Metabolomics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 16. World Untargeted Metabolomics Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 18. China Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 23. India Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Untargeted Metabolomics by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Untargeted Metabolomics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Untargeted Metabolomics Markets in 2025
Figure 27. United States VS China: Untargeted Metabolomics Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Untargeted Metabolomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Untargeted Metabolomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Untargeted Metabolomics Market Size Market Share by Type in 2025
Figure 31. Plant Untargeted Metabolomics
Figure 32. Human Untargeted Metabolomics
Figure 33. Other
Figure 34. World Untargeted Metabolomics Market Size Market Share by Type (2021-2032)
Figure 35. World Untargeted Metabolomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Untargeted Metabolomics Market Size Market Share by Application in 2025
Figure 37. Academic and Research Institutions
Figure 38. Pharmaceutical and Biotechnology Companies
Figure 39. World Untargeted Metabolomics Market Size Market Share by Application (2021-2032)
Figure 40. Untargeted Metabolomics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Untargeted Metabolomics Picture
Figure 2. World Untargeted Metabolomics Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Untargeted Metabolomics Total Revenue (2021-2032) & (USD Million)
Figure 4. World Untargeted Metabolomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Untargeted Metabolomics Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Untargeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 13. Untargeted Metabolomics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 16. World Untargeted Metabolomics Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 18. China Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 23. India Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Untargeted Metabolomics by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Untargeted Metabolomics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Untargeted Metabolomics Markets in 2025
Figure 27. United States VS China: Untargeted Metabolomics Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Untargeted Metabolomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Untargeted Metabolomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Untargeted Metabolomics Market Size Market Share by Type in 2025
Figure 31. Plant Untargeted Metabolomics
Figure 32. Human Untargeted Metabolomics
Figure 33. Other
Figure 34. World Untargeted Metabolomics Market Size Market Share by Type (2021-2032)
Figure 35. World Untargeted Metabolomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Untargeted Metabolomics Market Size Market Share by Application in 2025
Figure 37. Academic and Research Institutions
Figure 38. Pharmaceutical and Biotechnology Companies
Figure 39. World Untargeted Metabolomics Market Size Market Share by Application (2021-2032)
Figure 40. Untargeted Metabolomics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
